Likewise, Zhang et al. screened for possible MUC16 promoters and attempted specific expression utilizing follicle-stimulating hormone peptide-conjugated gro-α shRNA nanoparticle delivery to ovarian cancer cells [17]. Here, MUC16 is linked to ovarian carcinoma.